Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sihuan Pharmaceutical Holdings Group Ltd. has announced the market purchase of 5 million shares as part of its 2022 Share Award Scheme, representing approximately 0.05% of the total shares in issue. With a focus on the medical aesthetics and biopharmaceutical sectors, Sihuan Pharmaceutical aims to strengthen its position as a leading company in China. The share acquisition, executed at an average price of HK$0.5580 per share, aligns with the company’s strategic objectives and ongoing commitment to innovation and growth.
For further insights into HK:0460 stock, check out TipRanks’ Stock Analysis page.
